- Home
- FGI vs SBFM Comparison
FGI vs SBFM Comparison
Compare FGI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FGI | SBFM |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 7.2M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | FGI | SBFM |
|---|---|---|
| Price | $6.99 | $1.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 82.4K | 44.2K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $135,654,095.00 | $37,323,742.00 |
| Revenue This Year | $3.80 | $10.26 |
| Revenue Next Year | $6.26 | $32.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.66 | ★ 13.24 |
| 52 Week Low | $2.28 | $1.17 |
| 52 Week High | $12.62 | $3.90 |
Technical Indicators
Market Signals| Indicator | FGI | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 34.62 |
| Support Level | $5.51 | $1.35 |
| Resistance Level | $7.36 | $1.40 |
| Average True Range (ATR) | 1.28 | 0.08 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 34.03 | 45.45 |
Price Performance
Historical ComparisonAbout FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.